- NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
- NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
- NexImmune Announces 1-for-25 Reverse Stock Split
- NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy
- NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
More ▼
Key statistics
On Thursday, Neximmune Inc (NEXI:NAQ) closed at 3.12, 149.58% above the 52 week low of 1.25 set on Nov 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.13 |
---|---|
High | 3.20 |
Low | 3.07 |
Bid | 3.00 |
Offer | 3.52 |
Previous close | 3.12 |
Average volume | 14.17k |
---|---|
Shares outstanding | 1.37m |
Free float | 1.09m |
P/E (TTM) | -- |
Market cap | 4.28m USD |
EPS (TTM) | -30.86 USD |
Data delayed at least 15 minutes, as of May 02 2024 21:00 BST.
More ▼